Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07486882 · ClinicalTrials.gov registry record · NA
Comparing Acoustic Resonance Therapy (ART) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I)
A NA study of Chronic Insomnia Disorder, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07486882: Recruiting NA study of Chronic Insomnia Disorder, sponsored by Mayo Clinic.
NCT07486882 is a NA study of Chronic Insomnia Disorder that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07486882, a NA study of Chronic Insomnia Disorder, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare changes in sleep quality in patients with moderate to severe insomnia, in participants randomized to Cognitive Behavioral Therapy for Insomnia (CBT-I) arm versus those randomized to the SONU Headband Acoustic Resonance Therapy (ART) arm at end of treatment (6 weeks).
Primary Outcome
The Patient-Reported Outcomes Measurement Information System Sleep Disturbance instrument assesses self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep where a high score indicates self-reported perceptions of difficulties or concerns with sleep.
Conditions Studied
Interventions
- BEHAVIORAL Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I)
- DEVICE Acoustic Resonance Therapy (ART)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-17 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT07486882 shows while recruiting
NCT07486882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Chronic Insomnia Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first listed.
NCT07486882 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07486882 about?
NCT07486882 is a clinical study titled "Comparing Acoustic Resonance Therapy (ART) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I)". The purpose of this study is to compare changes in sleep quality in patients with moderate to severe insomnia, in participants randomized to Cognitive Behavioral Therapy for Insomnia (CBT-I) arm versus those randomized to the SONU Headband Acoustic Resonance Therapy (ART) arm at end of treatment (6 ...
What is the current status of trial NCT07486882?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03-17. Estimated completion is 2027-07-31.
What conditions does trial NCT07486882 study?
This clinical trial studies the following conditions: Chronic Insomnia Disorder.
What interventions are being tested in trial NCT07486882?
The interventions under investigation include: Mayo Clinic Cognitive Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL), Acoustic Resonance Therapy (ART) (DEVICE).
Who is sponsoring clinical trial NCT07486882?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07486882 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07486882's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI